Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Graft-versus-host disease | R-HSA-1643685 | map05332 | ketorolac | 3826 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ketorolac | 3826 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ketorolac | 3826 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ketorolac | 3826 | drug-path |
| Asthma | R-HSA-444620 | map05310 | ketorolac | 3826 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | ketorolac | 3826 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ketorolac | 3826 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ketorolac | 3826 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | ketorolac | 3826 | drug-path |
| Shigellosis | 0 | map05131 | ketorolac | 3826 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | ketorolac | 3826 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | ketorolac | 3826 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | ketorolac | 3826 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | ketorolac | 3826 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | ketorolac | 3826 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | ketorolac | 3826 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | orlistat | 3034010 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | orlistat | 3034010 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | orlistat | 3034010 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | orlistat | 3034010 | drug-path |